Literature DB >> 2307738

An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics.

J Costa1, E Khaled, J Sramek, W Bunney, S G Potkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2307738     DOI： 10.1097/00004714-199002000-00027

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

Review 1.  Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.

Authors:  Robert E McCullumsmith; John Hammond; Adam Funk; James H Meador-Woodruff
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

Review 2.  The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.

Authors:  Samuel M Cohen; Richard W Tsien; Donald C Goff; Michael M Halassa
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

3.  Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.

Authors:  Sumie Leung; Rodney J Croft; Barry V O'Neill; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-10-20       Impact factor: 4.530

Review 4.  Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.

Authors:  Seong S Shim; Michael D Hammonds; Baik S Kee
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

5.  Glycine treatment of the risk syndrome for psychosis: report of two pilot studies.

Authors:  Scott W Woods; Barbara C Walsh; Keith A Hawkins; Tandy J Miller; John R Saksa; Deepak C D'Souza; Godfrey D Pearlson; Daniel C Javitt; Thomas H McGlashan; John H Krystal
Journal:  Eur Neuropsychopharmacol       Date:  2012-10-22       Impact factor: 4.600

6.  Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study.

Authors:  Marc J Kaufman; Andrew P Prescot; Dost Ongur; A Eden Evins; Tanya L Barros; Carissa L Medeiros; Julie Covell; Liqun Wang; Maurizio Fava; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2009-06-24       Impact factor: 3.222

Review 7.  Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics.

Authors:  Mary-Anne B MacKay; John W Paylor; James T F Wong; Ian R Winship; Glen B Baker; Serdar M Dursun
Journal:  Front Psychiatry       Date:  2018-10-30       Impact factor: 4.157

Review 8.  Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.

Authors:  Andrea de Bartolomeis; Licia Vellucci; Mark C Austin; Giuseppe De Simone; Annarita Barone
Journal:  Biomolecules       Date:  2022-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.